Results 201 to 210 of about 13,399 (295)

Ristocetin: a clinical trial.

, 1958
C. E. van Rooyen, Alan J. MacLeod, Garth Embree   +2 more
openalex   +1 more source

Cooperativity and anti-cooperativity between ligand binding and the dimerization of ristocetin A: asymmetry of a homodimer complex and implications for signal transduction

, 1996
Younghoon R. Cho, Alison J. Maguire, Andrew C. Try, Martin S. Westwell, Patrick Groves, Dudley H. Williams   +5 more
openalex   +1 more source

Introduction to the Review Series. A century after Erik von Willebrand. [PDF]

Haematologica
Mannucci PM, Rodeghiero F.
europepmc   +1 more source

Biomarkers of Endothelial Damage and Disease Severity in COVID-19 Patients. [PDF]

Curr Issues Mol Biol
Tsiatsiou P, Pilalas D, Tsaireli V, Lanta A, Meletis G, Kassomenaki A, Tza E, Tampakas L, Gkeka H, Papaioannou M, Protonotariou E, Skoura L.   +11 more
europepmc   +1 more source

Studies Towards the Total Synthesis of Ristocetin A and Orienticin C Aglycones

, 2008
Diana V. Ciurea
openalex   +1 more source

Structure and multiple functions of von Willebrand factor. [PDF]

Haematologica
Haberichter SL, O'Donnell JS.
europepmc   +1 more source

Outcomes of recombinant activated factor VIIa (NovoSeven) therapy in glanzmann thrombasthenia: two case reports. [PDF]

Blood Coagul Fibrinolysis
Almatar E, Alsharidah S, Hashem OA.
europepmc   +1 more source

Ristocetin-induzierte Thrombozyten-Aggregation (RIPA) [PDF]

, 2019
openaire   +1 more source

Acquired von Willebrand syndrome secondary to monoclonal gammopathy: a single-center case series. [PDF]

Ther Adv Hematol
Van Thillo Q, Segers F, Brijs J, Douven U, Ramanan R, Delforge M, Janssens A, Hermans C, De Bent J, Jacquemin M, Vanassche T, Verhamme P.   +11 more
europepmc   +1 more source

Comparative Analysis of Pure VWF and VWF/FVIII Complex in Orthopedic Surgery for Type 2B von Willebrand Disease. [PDF]

Am J Case Rep
Chamouni P, Barbay V, Billoir P, Le Cam Duchez V.   +3 more
europepmc   +1 more source